Article Text

Download PDFPDF
British Cardiovascular Society Young Investigator Award 2022
  1. Chris Orsborne1,
  2. Raghav T Bhatia2,
  3. Ziwen C Li3,
  4. Hamish MacLachlan2,
  5. Marco Spartera4,5,
  6. Victoria M Stoll6
  1. 1 Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
  2. 2 Cardiovascular Clinical Academic Group and Cardiology Research Centre, St George’s, University of London, St George’s University Hospitals NHS Foundation Trust, London, UK
  3. 3 Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK
  4. 4 Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
  5. 5 Great Western Hospital NHS Foundation Trust, Swindon, UK
  6. 6 Adult Congenital Heart Disease, Royal Papworth Hospital Foundation Trust, Cambridge, UK
  1. Correspondence to Dr Victoria M Stoll, ACHD, Cardiology, Royal Papworth NHS Foundation Trust, Cambridge, UK; v.m.stoll{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

At the annual British Cardiovascular Society meeting marking the 100th centenary of the oldest Cardiac Society in the world five finalists were selected for the Young Investigator Award. The prize was established to ‘recognise excellence among young researchers intending to pursue a career in cardiovascular clinical medicine or research’. Finalists were selected following submissions of brief communications of original research from a large number of competitive applicants. Each finalist gave a 10 min oral presentation, followed by 5 min of questioning by the judges.

Winner: Dr Chris Orsborne

Dr Chris Orsborne is a clinical research fellow at the British Heart Foundation Manchester Centre for Heart and Lung Magnetic Resonance Research and a PhD student at the University of Manchester. His multidisciplinary supervisory team is led by Professor Chris Miller.

Dr Orsborne’s research focuses on inherited metabolic cardiomyopathy, specifically Fabry disease. Cardiac manifestations of Fabry disease are common and the leading cause of death, yet they are poorly understood and in the absence of robust prognostic models, it is difficult to identify and treat at-risk individuals. Dr Orsborne uses contemporary and novel imaging biomarkers to understand the pathophysiology, prognostication and treatments of Fabry disease. His primary goal is to develop a tool that identifies at-risk patients with Fabry disease, so that timely interventions can be made (figure 1).

Figure 1

Dr Chris Orsborne.

Dr Orsborne’s research developed and internally validated a risk …

View Full Text


  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.